AI assistant
ABBOTT LABORATORIES — Director's Dealing 2021
Feb 4, 2021
29777_dirs_2021-02-03_51f7b08f-d09d-4c6c-aed5-d32dae057d27.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2021-02-01
Reporting Person: ALLEN HUBERT L (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-01 | Common shares without par value | M | 107793 | $39.12 | Acquired | 259689 | Direct |
| 2021-02-01 | Common shares without par value | M | 95600 | $38.40 | Acquired | 355289 | Direct |
| 2021-02-01 | Common shares without par value | S | 201343 | $123.4659 | Disposed | 153946 | Direct |
| 2021-02-01 | Common shares without par value | S | 2050 | $124.0278 | Disposed | 151896 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-01 | Option (right to buy) | $39.12 | M | 107793 | Disposed | 2024-02-20 | Common Shares (107793) | Direct |
| 2021-02-01 | Option (right to buy) | $38.40 | M | 95600 | Disposed | 2026-02-18 | Common Shares (95600) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.00 to $123.99, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.00 to $124.19, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.